Your browser doesn't support javascript.
loading
Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation.
Rubio-Rivas, Manuel; Corbella, Xavier; Guillén-Del-Castillo, Alfredo; Tolosa Vilella, Carles; Colunga Argüelles, Dolores; Argibay, Ana; Vargas Hitos, José Antonio; Todolí Parra, José Antonio; González-Echávarri, Cristina; Ortego-Centeno, Norberto; Trapiella Martínez, Luis; Rodríguez Carballeira, Mónica; Marín Ballvé, Adela; Pla Salas, Xavier; Perales Fraile, Isabel; Chamorro, Antonio-J; Madroñero Vuelta, Ana Belén; Freire, Mayka; Ruiz Muñoz, Manuel; González García, Andrés; Pons Martín Del Campo, Isaac; Sánchez García, María Esther; Bernal Bello, David; Espinosa, Gerard; García Hernández, Francisco José; Sáez Comet, Luis; Ríos Blanco, Juan José; Fernández de la Puebla Giménez, Rafael Ángel; Sánchez Trigo, Sabela; Fonollosa Pla, Vicent; Simeón Aznar, Carmen Pilar.
Afiliação
  • Rubio-Rivas M; Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain. Electronic address: mrubio@bellvitgehospital.cat.
  • Corbella X; Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Group of Evaluation of Health Determinants and Health Policies, Hestia Chair in Integrated Health and Social Care, Faculty of Medicine and Health Sciences, U
  • Guillén-Del-Castillo A; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
  • Tolosa Vilella C; Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, Barcelona, Spain.
  • Colunga Argüelles D; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain.
  • Argibay A; Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra, Spain.
  • Vargas Hitos JA; Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada, Spain.
  • Todolí Parra JA; Department of Internal Medicine, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • González-Echávarri C; Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Bizkaia Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain.
  • Ortego-Centeno N; Inst Invest Biosanitaria Ibs Granada, Department of Internal Medicine, Unit of Systemic Autoimmune Diseases, Department of Medicine, Facultad de Medicina, Hospital Universitario San Cecilio, Granada, Spain.
  • Trapiella Martínez L; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, Asturias, Spain.
  • Rodríguez Carballeira M; Department of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, Barcelona, Spain.
  • Marín Ballvé A; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
  • Pla Salas X; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, Barcelona, Spain.
  • Perales Fraile I; Department of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, Madrid, Spain.
  • Chamorro AJ; Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.
  • Madroñero Vuelta AB; Department of Internal Medicine, Hospital General San Jorge, Huesca, Spain.
  • Freire M; Department of Internal Medicine, Hospital Clínico Universitario de Santiago, Santiago de Compostela, A Coruña, Spain.
  • Ruiz Muñoz M; Department of Internal Medicine, Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain.
  • González García A; Department of Internal Medicine, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Pons Martín Del Campo I; Department of Internal Medicine, Xarxa Assistencial Universitària de Manresa, Manresa, Barcelona, Spain.
  • Sánchez García ME; Department of Internal Medicine, Hospital Universitario Virgen de Valme, Sevilla, Spain.
  • Bernal Bello D; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain.
  • Espinosa G; Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain.
  • García Hernández FJ; Department of Internal Medicine, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Sáez Comet L; Department of Internal Medicine, Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • Ríos Blanco JJ; Department of Internal Medicine, Hospital Universitario La Paz, Madrid, Spain.
  • Fernández de la Puebla Giménez RÁ; Department of Internal Medicine, Hospital Universitario Reina Sofía, Córdoba, Spain.
  • Sánchez Trigo S; Department of Internal Medicine, Complejo Hospitalario Universitario de Ferrol, Ferrol, A Coruña, Spain.
  • Fonollosa Pla V; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
  • Simeón Aznar CP; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
Autoimmun Rev ; 19(5): 102507, 2020 May.
Article em En | MEDLINE | ID: mdl-32194200
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Causas de Morte País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Causas de Morte País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article